Wednesday, February 10, 2016

Super Bowl DTC Drug Ads Spark Backlash!

The backlash against direct-to-consumer (DTC) drug ads during the Super Bowl may not have been as furious as the backlash against Beyonce's tribute to Malcolm X, the Black Panthers and Black Lives Matter, but it did involve the White House, which specifically criticized a "PSA" about opioid-induced constipation (OIC). The ad was funded by AstraZeneca and Daiichi Sankyo, two companies in a joint venture to market Movantik, a drug that treats OIC.


The ad drew criticism from other quarters as well.

Tuesday, February 09, 2016

Number of Kids (and Adults) Without Health Insurance Continues to Tumble

As reported by STAT Morning Rounds:
"The number of people without health insurance in the US has continued to tumble: In the first nine months of 2015, just 9.1 percent of people didn’t have coverage. That means there are 16 million fewer uninsured people than in 2013, according to new data from the CDC. One group that’s seeing a big boost: children. The share of kids without insurance has dropped to just 4.5 percent, from 14 percent in 1997."
Source: CDC, where you can also find the data about adults.
Aside from these children (and adults), who has benefited from Obamacare?

Saturday, February 06, 2016

Digital-Savvy Women in Pharma Twitter Chat


I will be moderating the Digital-Savvy Women in Pharma Twitter chat (#dswpharma) in association with the Drug Information Association (@DrugInfoAssn) on February 17 at 1:00pm EST. This chat was inspired by the powerpoint presentation I posted on Slideshare a few weeks ago (see it here).

I hope you will join the conversation.

Here's the preliminary list of questions/topics to be discussed:

Thursday, January 28, 2016

FDA's 2016 Guidance Agenda - Just Like the 2014 & 2015 Agendas - Promises Publication of Guidance Regarding Use of Links to 3rd-Party Internet Sites

FDA/CDER has published its 2016 Guidance Agenda (here). Here's what's under the Advertising Category:
  • Health Care Economic Information in Promotional Labeling and Advertising for Prescription Drugs Under Section 114 of the Food and Drug Administration Modernization Act
  • Internet/Social Media Advertising and Promotional Labeling of Prescription Drugs and Medical Devices – Use of Links to Third-Party Sites
  • Manufacturer Communications Regarding Unapproved, Unlicensed, or Uncleared Uses of Approved, Licensed, or Cleared Human Drugs, Biologics, Animal Drugs and Medical Devices
  • Presenting Risk Information in Prescription Drugs and Medical Devices Promotion; Revised Draft
I highlighted one item on the list having to do with "Internet/Social Media Advertising" -- Use of Links to Third-Party Sites. This was also on FDA's 2014 AND 2015 Guidance Calendars, but as we know no web link guidance was issued in 2014 OR 2015.

Perhaps none will be issued in 2016 either. Why not?

Related Posts Plugin for WordPress, Blogger...